These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 10557058

  • 21. Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.
    Schoch C, Schnittger S, Bursch S, Gerstner D, Hochhaus A, Berger U, Hehlmann R, Hiddemann W, Haferlach T.
    Leukemia; 2002 Jan; 16(1):53-9. PubMed ID: 11840263
    [Abstract] [Full Text] [Related]

  • 22. Quantitative competitive reverse transcriptase-polymerase chain reaction for BCR-ABL on Philadelphia-negative leukaphereses allows the selection of low-contaminated peripheral blood progenitor cells for autografting in chronic myelogenous leukemia.
    Corsetti MT, Lerma E, Dejana A, Basta P, Ferrara R, Benvenuto F, Vassallo F, Abate M, Piaggio G, Parodi C, Sessarego M, Li Pira G, Manca F, Carella AM.
    Leukemia; 1999 Jul; 13(7):999-1008. PubMed ID: 10400414
    [Abstract] [Full Text] [Related]

  • 23. Persistence of transcriptionally silent BCR-ABL rearrangements in chronic myeloid leukemia patients in sustained complete cytogenetic remission.
    Kitzis A, Brizard F, Dascalescu C, Chomel JC, Guilhot F, Brizard A.
    Leuk Lymphoma; 2001 Jul; 42(5):933-44. PubMed ID: 11697648
    [Abstract] [Full Text] [Related]

  • 24. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse.
    Serrano J, Roman J, Sanchez J, Jimenez A, Castillejo JA, Herrera C, Gonzalez MG, Reina L, Rodriguez MC, Alvarez MA, Maldonado J, Torres A.
    Blood; 2000 Apr 15; 95(8):2659-65. PubMed ID: 10753848
    [Abstract] [Full Text] [Related]

  • 25. Real-time quantitation of bcr-abl transcripts in haematological malignancies.
    Saffroy R, Lemoine A, Brézillon P, Frénoy N, Delmas B, Goldschmidt E, Souleau B, Nedellec G, Debuire B.
    Eur J Haematol; 2000 Oct 15; 65(4):258-66. PubMed ID: 11073166
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics.
    Branford S, Hughes TP, Rudzki Z.
    Br J Haematol; 1999 Dec 15; 107(3):587-99. PubMed ID: 10583264
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Rare e14a3 (b3a3) BCR-ABL fusion in chronic myeloid leukemia in India: the threats and challenges in monitoring minimal residual disease (MRD).
    Vaniawala S, Acharya A, Parekh H, Mukhopadhyaya PN.
    Anal Cell Pathol (Amst); 2013 Dec 15; 36(3-4):85-92. PubMed ID: 24072036
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon.
    Lion T, Gaiger A, Henn T, Hörth E, Haas OA, Geissler K, Gadner H.
    Leukemia; 1995 Aug 15; 9(8):1353-60. PubMed ID: 7643624
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia.
    Langabeer SE, Gale RE, Harvey RC, Cook RW, Mackinnon S, Linch DC.
    Leukemia; 2002 Mar 15; 16(3):393-9. PubMed ID: 11896544
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.